Norway-Vadsø: Pharmaceutical products
Get tender notifications and more sign up now and never miss an opportunity again. Already a member? log in to your account.
Title | Norway-Vadsø: Pharmaceutical products |
OJEU (High Value) | 325024-2020 |
Type | Invitation to tender |
Date Published | 2020-07-10 |
Deadline | 2020-09-09 12:00:00 |
Nature Of Contract | Supply contract |
Awarding Authority | |
Procedure | Open procedure |
Description : |
I.1) Name and addresses: NUTS code: NO I.2.3) The contract is awarded by a central purchasing body Communication I.3) Procurement documents (URL):https://permalink.mercell.com/134076565.aspx Additional Information I.3.4) Additional information can be obtained from: I.3.6)Tenders or requests to participate must be submitted electronically via: https://permalink.mercell.com/134076565.aspx I.4) Type of the contracting authority: BODY PUBLIC I.5.1) Main Activity: HEALTH LIS 2103f Infusion and Flushing Fluids, Non-registered II.1.4) Short description The contracting authorities for this competition are the four regional health authorities in Norway; the South Eastern Norway Regional Health Authority, Western Norway Regional Health Authority, Central Norway Regional Health Authority and Northern Norway Regional Health Authority. II.01) Estimated value excluding VAT: NOK 2500000.00 II.1.6) This contract is divided into lots: no NUTS code: NO01 II.1.4) Short description Sykehusinnkjøp HF Divisjon Legemidler (LIS), on behalf of the four regional health authorities (RHA) would like to procure infusion and flushing fluids, non-registered medicines (LIS 2103 f.) II.2.5) Award criteria: Value excluding VAT: NOK 2500000.00 II.2.6) Duration of the contract, framework agreement or dynamic purchasing system II.2.7) II.2.7) II.2.7.5) This contract is subject to renewal: yes II.2.7.6) Description of renewals: The regional health companies, c/o the contract administrator, can extend all or parts of the framework agreement for up to 24 months. II.2.10) Variants will be accepted: no II.2.11) Options II.2.11.2) Description of options The regional health companies, c/o the contract administrator, can extend all or parts of the framework agreement for up to 24 months. The procurement is related to a project and/or programme financed by European Union funds): no III.1.3.2) List and brief description of selection criteria Tenderers must have a valid wholesaler licence or production licence. III.1.3.3) Minimum level(s) of standards possibly required Individual tenderers must document that they have a valid wholesaler licence or production licence for their preparations in the EU/EEA at the publication of call for tenders. IV.1.1) Type of procedure: Open Notice number in the OJ S 2019/S 209-512057 IV.2.1) Time limit for receipt of tenders or requests to participate IV.2.2) Date 2020-09-09 IV.2.2) Local time 12:00 IV.2.6) Tender must be valid until 2021-02-26 IV.2.7) Conditions for opening of tenders IV.2.7) Date 2020-09-09 IV.2.7) Local time 12:00 In approx. 24 months. VI.2.1) Electonic ordering will be used VI.2.2) Electronic invoicing will be accepted VI.2.3) Electronic payment will be used Review body: Body responsible for mediation procedures VI.04.04) Service from which information about the review Date of dispatch of this notice : 2020-07-08 |
CPV Codes |
33600000; Pharmaceutical products; |
Sign-up now to receive weekly OJEU reports for the UK, your sector and/or elsewhere in the EU. We also report on the procurement of EC Institutions. |
|